Arteris (AIP) CEO-linked LLC sells 40,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Arteris, Inc. President and CEO Charles K. Janac, through Bayview Legacy, LLC, reported open-market sales of 40,000 shares of Arteris common stock on March 25–26, 2026 at weighted average prices of $18.0309 and $18.3458. These trades were executed under a Rule 10b5-1 trading plan adopted on March 5, 2025. Following the transactions, Bayview Legacy, LLC holds 9,189,071 shares indirectly, while separate holding entries show Janac with 217,538 shares held directly and 56,252 shares held through the Charles and Lydia Janac Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 40,000 shares ($731,624)
Net Sell
4 txns
Insider
JANAC K CHARLES
Role
President and CEO
Sold
40,000 shs ($732K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 32,988 | $18.3458 | $605K |
| Sale | Common Stock | 7,012 | $18.0309 | $126K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 9,189,071 shares (Indirect, Bayview Legacy, LLC);
Common Stock — 217,538 shares (Direct)
Footnotes (1)
- Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.
FAQ
What insider transaction did Arteris (AIP) report for Charles K. Janac?
Arteris reported that an entity associated with President and CEO Charles K. Janac sold 40,000 shares of common stock in open-market transactions. The sales occurred on March 25–26, 2026 at weighted average prices around $18 per share.
Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025. Such plans pre-schedule trades, making the timing more routine rather than discretionary.
What additional Arteris (AIP) holdings does Charles K. Janac report?
Beyond the Bayview Legacy, LLC position, the Form 4 shows 217,538 Arteris shares held directly by Charles K. Janac and 56,252 shares held through the Charles and Lydia Janac Trust, for which he serves as trustee.